Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

Journal of Clinical Oncology

Volumn 19, Issue 12, 2001, Pages 3058-3065

  Weber, W A ^a   Ott, K ^a   Becker, K ^a   Dittler, H J ^a   Helmberger, H ^a   Avril, N E ^a   Meisetschlager G ^a   Busch, R ^a   Siewert, J R ^a   Schwaiger, M ^a   Fink, U ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG RESPONSE; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; MALE; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR REGRESSION;

EID: 0035876401     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.12.3058     Document Type: Article

References (36)

1. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
2. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: A prospective randomized trial
3. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus
4. Expression of the multidrug resistance protein (MRP) in squamous cell carcinoma of the oesophagus and response to pre-operative chemotherapy
5. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
6. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography
7. Evaluation of distant metastases in esophageal cancer: 100 Consecutive positron emission tomography scans
8. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
9. Preoperative chemotherapy of high dose 5-FU (HDFU) + folinic acid (HDFA) + biweekly cisplatin without (group A) or with paclitaxel (group B) in patients with locally advanced adenocarcinomas of the esophagus
10. Classification of adenocarcinoma of the oesophagogastric junction
11. Response to chemotherapy in esophageal cancer
12. Clinical value of diagnostic laparoscopy with laparoscopic ultrasound in patients with cancer of the esophagus or cardia
13. Adenocarcinoma of the gastro-esophageal junction: CT for monitoring during neoadjuvant chemotherapy
14. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules
15. Measurement of clinical and subclinical tumour response using f-18-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations
16. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer
17. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients
18. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients
19. Surgical resection for cancer of the cardia
20. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: Clinicopathologic correlations
21. Some practical issues of experimental design and data analysis in radiological ROC studies
22. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival
23. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma
24. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: Do histological assessment and p53 overexpression predict chemo-responsiveness?
25. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
26. Influence of chemotherapy on FDG uptake by human cancer xenografts in nude mice
27. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil
28. Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
29. Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
30. Reproducibility of metabolic measurements in malignant tumors using FDG PET
31. Reporting results of cancer treatment
32. Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy
33. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation
34. Zurich experience in osteogenic sarcoma: State of the art - Past, present or future?